KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Encompass Health (EHC) Shares Outstanding (Weighted Average) (2016 - 2025)

Encompass Health (EHC) has disclosed Shares Outstanding (Weighted Average) for 17 consecutive years, with $100.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 0.6% year-over-year to $100.5 million, compared with a TTM value of $100.5 million through Dec 2025, up 0.6%, and an annual FY2025 reading of $100.5 million, up 0.6% over the prior year.
  • Shares Outstanding (Weighted Average) was $100.5 million for Q4 2025 at Encompass Health, roughly flat from $100.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $100.6 million in Q2 2025 and bottomed at $99.0 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $99.6 million, with a median of $99.5 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) grew 0.81% in 2021, then grew 0.2% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $99.0 million in 2021, then grew by 0.2% to $99.2 million in 2022, then rose by 0.3% to $99.5 million in 2023, then rose by 0.4% to $99.9 million in 2024, then increased by 0.6% to $100.5 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for EHC at $100.5 million in Q4 2025, $100.5 million in Q3 2025, and $100.6 million in Q2 2025.